Posted 04 June 2014 - 12:05 PM
Decarboxylation of cannabis
The following information about decarboxylation was not written by Cannabis Chris, but was pulled from another site during part of my research for “Marijuana Decarboxylation: how to decarboxylate medical marijuana†and “What is Decarboxylation?“, as well as a future article with another method. This snippet about decarboxylation had too much good information for me to leave out.
After reading this information, along with a graph that shows decarboxylation temperatures, I will be doing some experimenting with a few more methods of decarboxylating marijuana and I will post the results here.
Anyway, here is some great information from one of the big pharma companies, about the decarboxylation process, some of the info is pretty boring, but please read it all. That way you will have the best understanding of the decarboxylation method you choose to go with…
…
“The decarboxylation step may be carried out prior to or after extraction with liquid CO2.
In a preferred embodiment the decarboxylation step … is conducted by heating the plant material to temperatures and for times which ensure at least 95% conversion of the acid cannabinoids from the acid form to their neutral form whilst ensuring thermal degradation of THC to CBN is less than 10%.
Decarboxylation of cannabinoid acids is a function of time and temperature, thus at higher temperatures a shorter period of time will be taken for complete decarboxylation of a given amount of cannabinoid acid. In selecting appropriate conditions for decarboxylation consideration must, however, be given to minimising thermal degradation of the desirable, pharmacological cannabinoids into undesirable degradation products, particularly thermal degradation of THC to cannabinol (CBN).
Preferably, decarboxylation is carried out in a multi-step heating process in which the plant material is:
i) heated to a first temperature for a first (relatively short) time period to evaporate off retained water and allow for uniform heating of the plant material; and
ii) the temperature is increased to a second temperature for a second time period (typically longer than the first time period) until at least 95% conversion of the acid cannabinoids to their neutral form has occurred.
Preferably the first step is conducted at a temperature in the range of 100° C. to 110° C. for 10–20 minutes. More preferably the first temperature is about 105° C. and the first time period is about 15 minutes.
If the plant material is derived from cannabis plants having a high CBD content (defined as >90% CBD as a percentage of total cannabinoid content), the second temperature is preferably in the range from 115° C. to 125° C., preferably about 120° C. and the second time period is in the range from 45 to 75 minutes, preferably about 60 minutes. More preferably the second temperature is in the range from 135° C. to 145° C., preferably 140° C. and the second time period is in the range from 15 to 45 minutes, preferably about 30 minutes. In another embodiment, most preferred for a mass of plant material greater than 4 kg, the second temperature is in the range from 140° C. to 150° C., preferably 145° C. and the second time period is in the range from 55–90 minutes. The latter conditions are preferred for processing amounts of, for example, 4–6 kg of starting plant material and the exact figures, particularly time, may vary slightly with increased mass.
If the plant material is derived from cannabis plants having a high THC content (defined as >90% THC as a percentage of total cannabinoid content), the second temperature is preferably in the range of 115° C. to 125° C., typically 120° C., and the second time period is preferably in the range of 45 minutes to 75 minutes, typically about 60 minutes. More preferably the second temperature is in the range of 100° C. to 110° C., typically 105° C., and the second time period is in the range of 60 to 120 minutes. In another embodiment, most preferred for a mass of plant material greater than 4 kg, the second temperature is in the range of 140° C. to 150° C., preferably 145° C., and the second time period is in the range of 45 to 55 minutes.
Most preferably the decarboxylation step is conducted at temperatures and for times which ensure at least 97% conversion of the acid cannabinoids to their neutral form, whilst ensuring thermal degradation of THC to CBN is less than 5%. …
The plant material used as the starting material for the extraction process is preferably ground, milled or otherwise processed to give a particle size of less than 2 mm, but preferably greater than 1 mm. Such treatment generally results in improved extraction of cannabinoids from the plant material, as packaging density is improved.â€
via Extraction of pharmaceutically active components from plant materials – GW Pharma Limited.
…
I really like the detailed information on the decarboxylation process here. The 2-stage temperature method seems to be worth looking into.
If this information sparks any new methods of decarboxylation for you, then please comment with your method and results.
[...] In order to give you the desired effect (psychoactive ability) , the cannabinoids in the marijuana material need to be activated. When THC is in it’s natural plant form, it is actually called THC-A, and does not get us high or medicated until it is heated past a certain temperature for a determined length of time. During the heating process, a reaction called decarboxylation takes place and removes the -A(carboxylic acid) part of the THC chain. Once the carboxylic acid is removed, the THC is psychoactive and is available for human uptake. Read more about the decarboxylation
The Lesser Known Cannabinoid
We all know that marijuana contains the cannabinoid THC or delta 9- tetrahydro cannabinol, having been told that is what gets you high and experiencing its wondrous effects. We as growers cultivate cannabis for the purpose of getting the high it creates when consumed and usually have the desire to obtain strains with the highest THC content possible. With all of the knowledge people are gaining from testing the marijuana plant we now know that cannabis has around 85 cannabinoids, so the general public only being familiar with one of them seems crazy.
Royal Queen Seeds is an European company that sells CBD oil for medicinal purposes. The THC content in this olive oil based product is < 0.2% so users don’t get high at all.
In today’s world with the cannabis culture growing rapidly, ground breaking scientific tests are beginning to be done all over the world and we are learning that there is much more to be discovered within the contents of this magical plant. One of the biggest discoveries found with modern research was with the second most concentrated cannabinoid - Cannabidiol, abbreviated CBD. THC and CBD are the two most abundant naturally occurring cannabinoids with THC accounting for 12-25% and CBD for >1-4% on average. If only a quarter of what researchers are saying about CBD is true then this medical breakthrough can have as large an impact on modern natural medicine as the discovery of antibiotics.
CBD is like a brother or sister to THC, because like all siblings sometimes you work symbiotically together and sometimes you’re combating or off setting one another. Unlike Cannabidiol, THC is a psychoactive compound (meaning it affects brain function by acting on the central nervous system, which can result in altering your mood, behavior, perception and cognition) and its effects are what users of cannabis feel the most when smoked. The high is responsible for the feeling of relaxation, the heightening of your senses and of course the inevitable snacking you shall do when it gives you a craving for the munchies. It also has medicinal uses for a multitude of symptoms including; mild to moderate pain, insomnia, depression, nausea and appetite loss, just to name a few. For some people though THC may cause anxiety or paranoia, often related to the feeling of time slowing down, which it of course is not.
The CBD is considered a non-psychoactive cannabinoid, although it may seem to have some psychoactive effects, it emits a high that is sedative and responsible for the relief most people look for medicinally. Its medicinal uses surpass those of any other cannabinoid we know of, including; reducing or preventing inflammation and nausea, diabetes, alcoholism, PTSD, schizophrenia, rheumatoid arthritis, epilepsy, cardiovascular disease, anti-psychotic, anti-anxiety and even as a pain killer against muscle spasms or neuropathic pain, which are traditionally harder to treat with any medicine, even pharmaceutically.
While both the THC and CBD cannabinoids individually have many beneficial properties when they are used together, as they come from the marijuana plant, their effects are far more impressive. When working alongside of the THC molecules CBD can negate some of the anxiety that THC causes as well as give relief for different types of pain than THC can. This makes nature the best doctor by combining them into a single plant because they are way more effective when administered together, especially for people with multiple symptoms. CBD appears to also antagonize the excitatory effects of THC by delaying the onset of the high, while also making it last as much as twice as long. Some of us refer to that as ‘creeper’ bud when the effect doesn’t seem to be there after consumption, but then all of a sudden…BOOM…it comes out of nowhere slamming you like a ton of bricks. Although marijuana does affects some people different than others, it likely you have experienced these antagonized effects.
Mammals, birds, reptiles and fish all have endocannabinoid compounds made by their bodies which are basically a “natural†produced THC called anandamide. Technically, anandamide (Ananda = bliss in Sanskrit + amide = chemical type) is a naturally occurring neurotransmitting compound that our bodies have circulating within them. Both THC and anandamide act thru cannabinoid receptors located on cells throughout our bodies and have similar effects on things such as; pain, appetite and memory. Receptors are merely gate keeper proteins embedded in cells that direct chemical signals from outside molecules into the cell, telling them to do something, kind of like an air traffic controller for our cells, but this communication only happens after a molecule or compound binds to them. A molecule that binds to a receptor is called a ligand and the receptors are very specific when it comes to what can bind to it and only certain compounds will bind to each type of receptor. It’s like a lock and key, only certain keys open specific doors and when the door is open you have a gateway, and in the case of receptors it’s a gateway for a directional signal. One single cell can have many different types of receptors attached to it that are made to communicate with different compounds.
Cannabinoids only affect us because our bodies contain these receptors that are made to bind to specific cannabinoid molecules. Human brains actually contain more cannabinoid receptors than any other G-protein coupled receptor! Our cells containing so many of these that bind specifically with the THC on top of the fact that our bodies produce their own form of “natural THC†(anandamide) however tiny the concentration, makes a lot of sense out of the fact that humans are so drawn to this plant. There is nothing unnatural about the utilization process our bodies go through with cannabinoids and marijuana is proving itself to be a very effective natural medicine and it should be available for use to patients who need it.
So far there are only two known cannabinoid receptors in our body that bind with THC; the CB1 receptors which are found in the brain and central nervous system, and the CB2 receptors that are distributed throughout the body, but mostly in the immune system. Other than the cannabinoids found in cannabis (which are of course the most powerful) and the ones our body naturally produces there are many other substances that minutely affect our internal endocannabinoid system, such as; Echinacea, turmeric, black pepper, cacao etc. These and few other consumables have also been found to bind with these same cannabinoid receptors.
Cannabidiol or CBD however, does not have much binding affinity to either of the two known cannabinoid receptors. It instead has a suppressive effect on the enzyme FAAH (or ‘fatty acid amide hydroxylase’) which is the enzyme responsible for breaking down and destroying anandamide. This suppressive reaction with CBD means that more anandamide will stay in your system and for longer periods of time. Anandamide favors the CB1 receptor, as does THC, therefore leaving fewer openings for the action of the THC binding to those receptors and in turn less of an effect.
While CBD doesn’t care to bind with CB1 or CB2 it has been shown to interact with other receptors to enable its medicinal effects. There are a couple G-protein receptors located in the central and peripheral nervous systems that interact with CBD. Then there is the TRPV-1(technical abbreviation for ‘transient receptor potential cation channel subfamily V’) that reacts to it. The TRPV-1 receptor which also is activated by capsaicin, the ‘hot’ compound found in chili peppers, is known to mediate pain perception, inflammation and body temperature, as you have probably felt some of these effects from eating a very hot pepper.
A big roll is played in anxiety within our bodies by the family of 5-HT receptors, which are activated by the neurotransmitter serotonin. These receptors trigger responses via chemical messages that are either excitatory or inhibitory depending on the chemical context of the bind. The 5-HT1A serotonin receptor is member of that receptor family that binds to CBD and when activated by it exerts the cannabinoids heavy anti-depressant effects, which then trickles down into some of the other medicinal functions CBD gives because this receptor also works in a wide array of processes including anxiety, addiction, appetite, sleep, pain perception, nausea, vomiting etc. It does this by activating an inhibitory response, slowing down its signaling, compared to other drugs like LSD, mushrooms and hallucinogens alike that activate a different 5-HT receptor producing an excitatory response.
CBD emits some of its anti-anxiety effects by activating receptors called adenosine receptors. These regulate cardiovascular functions, myocardial oxygen consumption and coronary blood flow, opening up many of the symptoms of anxiety; tenseness, tightness in the chest, shortness of breath etc. These receptors are significant regulators in the brain for other neurotransmitters like dopamine and glutamate. Dopamine is not only responsible for inducing pleasurable feelings but can affect sleep, mood, memory, attention and voluntary movement. Other drugs such as cocaine and methamphetamine act by amplifying the effects of dopamine receptors as well but on a way larger scale. While THC temporarily enhances dopamine levels CBD does not, it has only been found to be sporadic in research done on mice and rats mostly working as an inhibitor. More research is needed into why this is and how it only happens randomly. Maybe it’s related to one of the other 83 cannabinoids we know so little about.
Both CBD and THC individually have been proven to work against cancer, but they have synergy when combined. We are in need of enhanced clinical trials to pinpoint exactly what functions they have when they are working together in the form of cannabis. Due to the unfortunate fact that cannabis cultivation and use is still restricted or forbidden in most parts of the world today, leads to the lack of funding and resources needed from governments and agencies to do such research. While there have been some university and collegiate studies done across the globe that compile enough compelling evidence pointing to a possible lead on the cannabis/cancer relationship, it is not definitive as of yet. This possible lead involves another G-protein coupled receptor called the GPR55, sometimes referred to as the orphan receptor because it hasn’t been scientifically placed into a family of receptors although many researchers believe it to be a third cannabinoid receptor. The GPR55’s are mainly found throughout the brain, with a concentration in and around the cerebellum and it is utilized regulating bone density and blood pressure. One example is when you have an overactive GPR55 receptor its signaling is increased and can be linked to osteoporosis. The receptor promotes osteoclast cell behavior, and osteoclast is responsible for bone reabsorption, a process in which bone calcium is broken down and transferred from the bone to the blood, rendering it weaker. This receptor when activated also aids in the rapid growth (proliferation) of cancer cells and has been linked to many different types of cancer. CBD has been shown in some studies to block GPR55 signaling, thereby decreasing both cancer cell proliferation as well as bone reabsorption and exerting its anti-cancer effects.
Most tests for illegal cannabis are tests for THC and in most countries CBD by itself is completely LEGAL and you can purchase it in many forms by itself. Unfortunately it will not have all of the same effects it would if it was in the combinations found in cannabis but it can work medicinal wonders even on its own. University studies have proved that it has tremendous effects on mice reducing rheumatoid arthritis inflammation by 50% and even reducing the infarct (necrosis) size by 65% when taken immediately after a heart attack.
-
Budgie, Dekay, weedtroll and 6 others like this